pageInfo({
    time : "1261528937642"
  
	    , page : null
	  
	    , url : null
	  
	    , instrument : null
	  
	    , article : {
	        storyId : "USN1050095520090710"
	        , headline : "UPDATE 1-Vertex to sell rights to hepatitis C drug payments"
	        , keywords : "[Biotechnology, Mergers and Acquisitions (including Changes of Ownership), Pharmaceuticals (sub-industry), United States of America, Pharmaceuticals - generic and speciality, Healthcare, Pharmaceuticals and biotechnology, Business activities, Economic news, EC, business/financial pages]"
	        , tickers : "[ch;JNJ, us;VRTX, us;JNJ, mx;JNJ, JNJ.N, de;VX1X, de;VX1S, de;VX1F, de;VX1, de;JNJS, de;JNJF, de;JNJ, VRTX.O]"
	    }
	    , channel : {
	        id : "4572"
	        , name : "americasMergersNews"
	        , title : "Mergers & Acquisitions - Americas"
	    }})